Investegate |RedHill Biopharma Announcements | RedHill Biopharma: RDHL Opaganib Selected by NIH RNCP For Development
Investegate announcements from RedHill Biopharma, RDHL Opaganib Selected by NIH RNCP For Development
United Kingdom Dror Ben Asher Redhill Biopharma Adi Frish Nuclear Countermeasures Program National Institute Of Allergy
Source: investegate.co.uk